SI1575621T1 - Formulacije kontrastnih medijev z izboljšano biološko toleranco - Google Patents

Formulacije kontrastnih medijev z izboljšano biološko toleranco

Info

Publication number
SI1575621T1
SI1575621T1 SI200331689T SI200331689T SI1575621T1 SI 1575621 T1 SI1575621 T1 SI 1575621T1 SI 200331689 T SI200331689 T SI 200331689T SI 200331689 T SI200331689 T SI 200331689T SI 1575621 T1 SI1575621 T1 SI 1575621T1
Authority
SI
Slovenia
Prior art keywords
contrast media
improved biological
biological tolerance
media formulations
formulations
Prior art date
Application number
SI200331689T
Other languages
English (en)
Slovenian (sl)
Inventor
Milos Sovak
Allen L Seligson
Ronald C Terry
Original Assignee
Biophysica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Inc filed Critical Biophysica Inc
Publication of SI1575621T1 publication Critical patent/SI1575621T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SI200331689T 2002-12-12 2003-11-07 Formulacije kontrastnih medijev z izboljšano biološko toleranco SI1575621T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
EP03786628A EP1575621B1 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance
PCT/US2003/035762 WO2004054637A2 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Publications (1)

Publication Number Publication Date
SI1575621T1 true SI1575621T1 (sl) 2010-01-29

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331689T SI1575621T1 (sl) 2002-12-12 2003-11-07 Formulacije kontrastnih medijev z izboljšano biološko toleranco

Country Status (18)

Country Link
US (1) US7250153B2 (https=)
EP (1) EP1575621B1 (https=)
JP (1) JP2006509841A (https=)
KR (1) KR101067159B1 (https=)
CN (1) CN1738651A (https=)
AT (1) ATE447416T1 (https=)
AU (1) AU2003295442B2 (https=)
CA (1) CA2509035C (https=)
CY (1) CY1110105T1 (https=)
DE (1) DE60329939D1 (https=)
DK (1) DK1575621T3 (https=)
ES (1) ES2333863T3 (https=)
IL (1) IL169119A (https=)
NO (1) NO332350B1 (https=)
NZ (1) NZ541139A (https=)
PT (1) PT1575621E (https=)
SI (1) SI1575621T1 (https=)
WO (1) WO2004054637A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE529135T1 (de) * 2004-03-11 2011-11-15 Mallinckrodt Llc Röntgenkontrastformulierung mit einem gemisch aus einem jodierten monomer und dimer
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
EP2240432B1 (en) 2008-01-14 2012-07-04 Mallinckrodt LLC Process for the preparation of iosimenol
JP5947784B2 (ja) * 2010-03-23 2016-07-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ 安定化x線診断用組成物の製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523295B2 (en) 1978-07-04 1982-07-22 Nycomed Imaging As X-ray contrast agent
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
AU6114396A (en) * 1995-06-16 1997-01-15 Biophysica Foundation Formyl derivatives as nonionic contrast media
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
IL169119A0 (en) 2007-07-04
DE60329939D1 (de) 2009-12-17
CN1738651A (zh) 2006-02-22
DK1575621T3 (da) 2009-12-14
EP1575621B1 (en) 2009-11-04
PT1575621E (pt) 2009-11-13
NZ541139A (en) 2008-07-31
AU2003295442B2 (en) 2008-11-06
NO20053343L (no) 2005-09-08
ATE447416T1 (de) 2009-11-15
NO332350B1 (no) 2012-09-03
KR20050088312A (ko) 2005-09-05
WO2004054637A3 (en) 2004-09-16
CA2509035A1 (en) 2004-07-01
EP1575621A4 (en) 2008-11-26
ES2333863T3 (es) 2010-03-02
EP1575621A2 (en) 2005-09-21
AU2003295442A1 (en) 2004-07-09
US20050025711A1 (en) 2005-02-03
US7250153B2 (en) 2007-07-31
CY1110105T1 (el) 2015-01-14
CA2509035C (en) 2011-07-19
KR101067159B1 (ko) 2011-09-22
WO2004054637A2 (en) 2004-07-01
JP2006509841A (ja) 2006-03-23
NO20053343D0 (no) 2005-07-08
IL169119A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
EP1240915A3 (en) Wire having a definied location of frangibility
DK1472344T3 (da) Bakteriofaglysin
WO2003061593A3 (en) Novel targeted compositions for diagnostic and therapeutic use
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
WO2007039858A3 (en) Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition
WO2007070855A3 (en) Medical device wireless adapter
WO2004064595A3 (en) Multivalent constructs for therapeutic and diagnostic applications
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
PL372146A1 (en) Orally administrable composition for the photoprotection of the skin
WO2004073623A3 (en) Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
IT1319258B1 (it) Catalizzatore per la idrodeclorurazione del tetracloruro di carbonio acloroformio.
WO2003078574A3 (en) Novel metabolic targets and markers
CY1110105T1 (el) Σκευασματα σκιαγραφικων μεσων που εχουν βελτιωμενη ανεκτικοτητα
MX2007003196A (es) Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
EP1281887A3 (de) Rundlager
ITMI20031382A1 (it) Sistema di disinnesto per l'azionamento di una frizione e procedimento per il montaggio di un sistema di disinnesto.
WO2006071949A3 (en) Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
WO2006034392A3 (en) Therapeutic quinones
Covell The Study of Japanese Buddhist Culture Topics for Consideration
TH87788A (th) สูตรยาที่มีการปล่อยคงที่และการใช้ของสิ่งนั้น
Nolan The Tacit Culture of Ottawa Emergency Medical Services
TW200612893A (en) Pharmaceutical formulation
UA27412U (en) Albuminous surgical adhesive
ZA200110546B (en) Zinc based alloy bolus for veterinary use.